Author: Calvi, Emiliano; Bernardi, Nicola; Cimino, Giuliana; Pascariello, Greta; Faggiano, Pompilio; Gavazzi, Emanuele; Vizzardi, Enrico; Metra, Marco
Title: Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series Cord-id: h352ilp4 Document date: 2020_12_29
ID: h352ilp4
Snippet: BACKGROUND: COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. CASE SUMMARY: We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic re
Document: BACKGROUND: COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. CASE SUMMARY: We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed evidence of unusual intracardiac thrombosis with thrombi adherent to regularly contracting walls. DISCUSSION: This evidence confirms that COVID-19 induces a hypercoagulable state which can result in intracardiac thrombosis. Therefore, TTE is indicated in all COVID-19 patients for early diagnosis, and prompt anticoagulant therapy is to be considered as a thromboprophylaxis strategy.
Search related documents:
Co phrase search for related documents- abnormal coagulation and low molecular weight: 1, 2, 3, 4, 5, 6, 7
- abnormal coagulation and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date